GO
Loading...

Piper Jaffray Companies

More

  • UPDATE 2-Gambro acquisition boosts Baxter's sales Thursday, 17 Jul 2014 | 1:30 PM ET

    July 17- Medical device and drug maker Baxter International Inc reported higher-than-expected quarterly adjusted earnings, driven primarily by a surge in sales of the dialysis products it gained from its acquisition of Gambro AB last year.

  • *Expects adj rev$ $264- $265 mln vs prior view $274- $280 mln. *Expects adj profit at low end of its 26- 28 cents/ shr view. "This was a reality check quarter for Riverbed as the company faces a myriad of company-specific and secular challenges in the field," FBR Capital Markets analyst Daniel Ives said in an email.

  • July 1- Buyout firm Berkshire Partners LLC is in advanced talks to acquire Portillo's Restaurant Group, the largest privately owned restaurant chain in the U.S. Berkshire Partners has outbid other private equity firms for the Chicago- based restaurant group, the sources said on Tuesday.

  • Del Taco is owned by private equity firms that include Goldman Sachs Mezzanine Partners, Charlesbank Capital Partners and Leonard Green& Partners. The owners are working with Piper Jaffray and Goldman Sachs Group Inc on the sale process, the sources said, requesting anonymity because the matter is private.

  • DUBLIN, June 10- The European Commission will launch a formal investigation on Wednesday into Apple Inc's tax arrangements in Ireland, Irish state broadcaster RTE reported, without naming its source.

  • DUBLIN, June 10- The European Commission will launch a formal investigation on Wednesday into Apple Inc's tax arrangements in Ireland, Irish state broadcaster RTE reported, without naming its source.

  • May 29- Teen apparel retailer Abercrombie& Fitch Co's quarterly sales fell less than expected for the first time in six quarters as efforts to revitalize its women's clothing business began to pay off, sending the company's shares up as much as 7.5 percent.

  • Valeant's New York- listed shares dropped 1 percent by midday to $128.66, paring earlier losses, while Allergan stock lost 4.1 percent to $158.29. Valeant on Wednesday offered to pay $58.30 per Allergan share in cash, about $10 higher than its previous offer of $48.30.

  • UPDATE 2-Valeant injects cash into bid for Botox maker Wednesday, 28 May 2014 | 9:06 AM ET

    Valeant on Wednesday offered to pay $58.30 per Allergan share in cash, about $10 higher than its previous offer of $48.30. The new offer values Allergan at $166.16 per share as of Tuesday's closing price, and is about 8.6 percent higher than the previous bid of $153 as on April 22 when Valeant first made its offer.

  • May 27- Aeropostale Inc said it secured a $150 million credit facility from private equity firm Sycamore Partners, in what could be a lifeline for the struggling teen apparel retailer. Shares of Aeropostale, which reported its sixth straight quarterly loss last week, rose as much as 17 percent on the New York Stock Exchange on Tuesday.

  • May 12- The brokerage unit of Stifel Financial Corp must pay a total of $2.7 million to a former head trader who said the firm defamed him and wrongfully withheld his bonus payment, a securities arbitration panel has ruled.

  • May 2- Acorda Therapeutics Inc said the U.S. Food and Drug Administration rejected its nasal form of the current standard therapy for epilepsy patients who experience repetitive seizures.

  • April 24- Zimmer Holdings Inc said on Thursday it would buy rival orthopedic products maker Biomet Inc for more than $13 billion, the latest deal in a wave of consolidations in the healthcare industry. The deal is expected to take Zimmer from the fourth-largest seller of orthopedics products to No. 2, behind Johnson& Johnson.

  • April 21- Hasbro Inc reported a better-than-expected quarterly profit on strong demand for toys such as My Little Pony, that have strong tie-ins with TV shows aimed at little girls. Hasbro's shares rose as much as 4.2 percent to touch an all-time high of $56.91 in early trading on Monday.

  • April 17- Google Inc's disappointing first-quarter results left Wall Street unfazed about the internet giant's ability to come to grips with the shift to the fast-growing mobile advertising market. Google shares were down about 3 percent in early trading on Thursday, and at least 12 brokerages cut their target price on the stock.

  • More than a dozen companies were lined up to go public this week but four, including Lombard Medical and Stalwart Tankers, failed to price on Thursday. Zoe's Kitchen raised about $87.5 million after its IPO of 5.83 million shares was priced at $15, the upper-end of the expected price range.

  • April 10- Zoe's Kitchen Inc priced its initial public offering at $15 on Thursday, valuing the Mediterranean-style restaurant chain at about $276 million. The company earlier this week expected the IPO to be priced between $13 and $15 per share. Birmingham, Alabama- based Zoe's Kitchen is selling all the shares in the offering.

  • April 4- Halozyme Therapeutics Inc halted a mid-stage trial testing an advanced version of its flagship drug delivery technology in patients with pancreatic cancer, sending its shares tumbling 32 percent.

  • NEW YORK, April 3- U.S. stocks fell on Thursday afternoon, led by a sharp drop in biotech and momentum stocks, including Facebook, Tesla and Netflix.

  • US STOCKS-Wall St little changed after claims, ISM data Thursday, 3 Apr 2014 | 10:54 AM ET

    NEW YORK, April 3- U.S. stocks were little changed on Thursday, with the S&P 500 holding near its recent record, as investors exercised restraint before Friday's employment report and data suggested modest improvement in the economy.